FDA Classification: Non-Medicated Topical Formulations for Erectile Dysfunction
Stay ahead in medical device compliance with this detailed course on the FDA’s classification of non-medicated topical formulations for erectile dysfunction. Learn the specific requirements, including biocompatibility, non-clinical performance, shelf life, and labeling standards. Gain actionable insights into meeting premarket notification (510(k)) obligations, understanding special controls, and managing risks. This training prepares manufacturers, sponsors, and regulatory professionals to achieve market authorization and avoid costly enforcement actions under the latest FDA rule.
In this course you will learn the following:
* Understand the FDA’s classification process for new medical devices, specifically the De Novo pathway.
* Identify the key requirements and special controls for non-medicated topical formulations for erectile dysfunction.
* Implement the necessary steps to ensure compliance with the new classification and special controls.
* Recognize the legal and regulatory consequences of failing to comply with the final rule.
NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year. At the end of the one year term, the course will be set to “inactive”.
